Symbol
SpringWorks Therapeutics
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$36.99
Current price of the stock
$3M
Trading volume of the stock
$2.7B
Market capitalization of the company
Mid Cap
Category of market capitalization
41.41%
Long-term growth mean estimate
5.00
Mean analyst rating
97.01%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
6.16
Current ratio
93.22%
Gross profit margin
-117.52%
Operating profit margin
-117.52%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-108.58%
Pretax profit margin
-108.58%
Net profit margin
-10.05%
Measures profitability relative to shareholders' equity
-10.05%
ROE excluding intangible assets
-8.79%
Measures profitability relative to total assets
-10.05%
Measures profitability relative to invested capital
0.08
Asset turnover ratio
0.34
Inventory turnover ratio
1.50
Receivables turnover ratio
60.19
Average number of days it takes to collect receivables
-9.51
Measures valuation relative to earnings
-15.94
P/E based on future earnings estimates
21.12
Measures valuation relative to sales
5.16
Measures valuation relative to book value
-4.51
Measures valuation relative to operating cash flow
-4.41
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
